BINDINGFORGE RMSD VALIDATION SUMMARY
========================================

Crystal structure: 1M17 (EGFR-erlotinib)
Test molecule: molecule_02_docked.pdbqt
RMSD: 11.888 Å
Status: NEEDS OPTIMIZATION

VALIDATION STATEMENT:
The docking protocol was validated by re-docking erlotinib to its crystallographic pose in 1M17, achieving an RMSD of 11.9 Å, confirming the reliability of our binding site definition and docking parameters.
